Home Featured Report: Seattle’s Life Science Market Continues to Normalize, Finishes 2022 Strong
FeaturedIndustry NewsLife Science

Report: Seattle’s Life Science Market Continues to Normalize, Finishes 2022 Strong

Share
Seattle, Puget Sound, CBRE, National Institutes of Health
Image Courtesy of Ryan Wilson
Share

By Kate Snyder The life science industry continues to normalize after the past couple of years of increased growth. A recent report from CBRE shows that the fourth quarter of 2022 was a varied one for the Puget Sound region’s life science market. According to the report, “Despite Economic Headwinds, Life Sciences Market Finishes 2022 […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

Nuveen Buys 91,000 SQFT Safeway-Anchored Redondo Square in Des Moines for $32.1MM

The $32.1 million Redondo Square deal comes as CBRE reports institutional buyers...

Cobalt Completes 174-Unit The Heights at Happy Valley, Adding Live-Work Units on Rock Creek Corridor

Cobalt's July delivery on the Rock Creek corridor pairs one- to three-bedroom...

Kōz Development’s 169-Unit Kōz on Wetmore in Downtown Everett Nears 2027 Opening

Kōz Development's 169-unit Kōz on Wetmore in downtown Everett is well underway...

Veritas Equity Partners Buys 70-Unit Viking Apartments in Lynnwood for $10MM

The 1962-built, seven-building complex near Edmonds College traded about 26 percent below...